Tyrosine kinase inhibitors in sarcoma treatment

Sarcomas are a group of rare mesenchymal malignant tumors that arise from transformed cells of the mesenchymal connective tissue, which are challenging to treat. The majority of sarcomas are soft tissue sarcomas (STSs; 75%) and this heterogeneous group of tumors is further comprised of gastrointesti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology letters 2022-06, Vol.23 (6), p.183, Article 183
Hauptverfasser:	Kyriazoglou, Anastasios, Gkaralea, Lydia Evangelia, Kotsantis, Ioannis, Anastasiou, Maria, Pantazopoulos, Anastasios, Prevezanou, Maria, Chatzidakis, Ioannis, Kavourakis, Georgios, Economopoulou, Panagiota, Nixon, Ioanna Fragkandrea, Psyrri, Amanda
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimitotic agents Antineoplastic agents Bone cancer Cancer Cancer therapies Chemotherapy Clinical trials Cytotoxicity Disease Drug approval Drug therapy Ewings sarcoma Gastrointestinal cancer Growth factors Health aspects Liposarcoma Medical prognosis Metastasis Phenols Radiation Review Sarcoma Stem cells Tumors Tyrosine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!